Lung Diseases, Obstructive
"Lung Diseases, Obstructive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Descriptor ID |
D008173
|
| MeSH Number(s) |
C08.381.495
|
| Concept/Terms |
Lung Diseases, Obstructive- Lung Diseases, Obstructive
- Lung Disease, Obstructive
- Obstructive Lung Disease
- Obstructive Lung Diseases
- Obstructive Pulmonary Diseases
- Obstructive Pulmonary Disease
- Pulmonary Disease, Obstructive
- Pulmonary Diseases, Obstructive
|
Below are MeSH descriptors whose meaning is more general than "Lung Diseases, Obstructive".
Below are MeSH descriptors whose meaning is more specific than "Lung Diseases, Obstructive".
This graph shows the total number of publications written about "Lung Diseases, Obstructive" by people in this website by year, and whether "Lung Diseases, Obstructive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 3 | 2 | 5 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2020 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Diseases, Obstructive" by people in Profiles.
-
Guedes AG, Dileepan M, Jude JA, Deshpande DA, Walseth TF, Kannan MS. Role of CD38/cADPR signaling in obstructive pulmonary diseases. Curr Opin Pharmacol. 2020 04; 51:29-33.
-
Deshpande DA. Editorial overview: Pulmonary 2020 - advances in the pharmacology of obstructive lung diseases. Curr Opin Pharmacol. 2020 04; 51:iii-vii.
-
Nevler A, Brown SZ, Nauheim D, Portocarrero C, Rodeck U, Bassig J, Schultz CW, McCarthy GA, Lavu H, Yeo TP, Yeo CJ, Brody JR. Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progression. J Am Coll Surg. 2020 04; 230(4):659-667.
-
Hirani A, Cavallazzi R, Vasu T, Pachinburavan M, Kraft WK, Leiby B, Short W, Desimone J, Squires KE, Weibel S, Kane GC. Prevalence of obstructive lung disease in HIV population: a cross sectional study. Respir Med. 2011 Nov; 105(11):1655-61.
-
Gerber RB, Kavuru M. Does salmeterol increase mortality in patients with COPD? Cleve Clin J Med. 2001 Jul; 68(7):600-1.
-
Sneider MB, Kazerooni EA. Radiography and computed tomography of chronic obstructive pulmonary disease. Semin Roentgenol. 2001 Jan; 36(1):66-73.
-
Pochettino A, Kotloff RM, Rosengard BR, Arcasoy SM, Blumenthal NP, Kaiser LR, Bavaria JE. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results. Ann Thorac Surg. 2000 Dec; 70(6):1813-8; discussion 1818-9.
-
Khan SU, Kavuru MS. A 56-year-old woman with mixed obstructive and restrictive lung disease. Respir Care. 2000 May; 45(5):533-4.
-
Nathan RA, Bernstein JA, Bielory L, Bonuccelli CM, Calhoun WJ, Galant SP, Hanby LA, Kemp JP, Kylstra JW, Nayak AS, O'Connor JP, Schwartz HJ, Southern DL, Spector SL, Williams PV. Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction. J Allergy Clin Immunol. 1998 Dec; 102(6 Pt 1):935-42.
-
Cohen JL, Cheirif J, Segar DS, Gillam LD, Gottdiener JS, Hausnerova E, Bruns DE. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. J Am Coll Cardiol. 1998 Sep; 32(3):746-52.